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436Efﬁcacy of right axillary artery perfusion for
antegrade cerebral perfusion in open total arch
repair
ArudoHiraoka, MD, Genta Chikazawa,MD, PhD, Toshinori Totsugawa,MD, PhD, Kentaro Tamura,MD,
Taichi Sakaguchi, MD, PhD, Kosuke Nakajima, CE, andHidenori Yoshitaka, MD, PhD, Okayama, Japan
Objective: Right axillary artery (RAxA) perfusion was introduced for selective antegrade cerebral perfusion in total aortic
arch repair to prevent cerebral embolism derived from arterial cannulation. However, the strategic beneﬁts and long-term
results regarding the cannulation site remain controversial. We retrospectively compared the outcomes between pro-
pensity score-matched patients with and without using RAxA cannulation.
Methods: Between 2006 and 2012, 260 consecutive patients underwent total arch repair with antegrade cerebral perfusion
and moderate hypothermia at a single institution. RAxA cannulation was added in 142 patients (54.6%), and 70 pro-
pensity score-matched pairs were obtained.
Results: There were no signiﬁcant differences in 30-day (2.9% [2 of 70] vs 5.7% [4 of 70]; P [ .415 and in-hospital
death (5.7% [4 of 70] vs 5.7% [4 of 70]; P [ 1.000) between matched pairs. Although there was no signiﬁcant differ-
ence in the occurrence of postoperative stroke (8.6% [6 of 70] vs 8.6% [6 of 70]; P [ 1.000), the new rate of new
occurrence of postoperative paraparesis was lower in patients with RAxA perfusion (0% [0 of 70] vs 4.3% [3 of 70];
P[ .067). With a mean follow-up period of 1057 6 686 days, the overall 5-year survival was 90.6% and was 89.6% for
patients with RAxA perfusion. Thee difference in survival between patients with and without RAxA perfusion was not
signiﬁcant.
Conclusions: RAxA perfusion is a useful option for total aortic arch repair, and the midterm outcomes were satisfactory.
However, RAxA perfusion did not completely prevent stroke in patients with an atherothrombotic aorta. (J Vasc Surg
2014;60:436-42.)Open aortic arch repair with a combination of hypo-
thermic circulatory arrest (HCA) and selective antegrade
cerebral perfusion (SACP) is an established option for
various aortic pathologies, and the efﬁcacy has been veri-
ﬁed.1-4 However, cerebral embolism derived from arterial
cannulation can occur, and postoperative neurologic
adverse events are still critical issues. As a preventive mea-
sure, right axillary artery (RAxA) perfusion was introduced
for SACP in aortic arch repair, and the efﬁcacy has been re-
ported.5-7 However, the lack of randomized trials and
different inclusion criteria do not advocate a general recom-
mendation for incorporating RAxA perfusion in aortic
arch repair.8 Thus, to date, the real beneﬁt of AxA cannula-
tion techniques in open total arch repair and long-term
results regarding the cannulation site remain controversial.
To evaluate the precise efﬁcacy of RAxA cannulation, we
retrospectively compared the outcomes between patientsthe Department of Cardiovascular Surgery, The Sakakibara Heart
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nulation in open total arch repair with HCA and SACP.
METHODS
This study was approved by the Institutional Review
Board. Informed consent requirements for patients who
participated were waived for this study.
Patients. Between January 2006 and December 2012,
260 consecutive patients (79 women [30.3%]) underwent
open total aortic arch repair with HCA and SACP at a single
cardiovascular institute. Average age was 71.3 6 11.0 years
(range, 35-92 years). Aortic pathology, including atheroscle-
rosis of the aorta and aortic dissection, were detected by pre-
operative contrast-enhanced computed tomography applied
in the entire cohort. An emergency operation was performed
in 88 patients (33.8%).
Of all patients, RAxA cannulation was added in 142
patients (54.6%). We retrospectively compared the out-
comes between the 142 patients with and the 118 without
RAxA cannulation and evaluated the efﬁcacy of RAxA
perfusion by propensity score-matching to reduce the ef-
fect of the different backgrounds of patients and potential
confounding.
Surgical procedure. General anesthesia was initiated,
and transesophageal echocardiography and transcutaneous
cerebral oximetry monitoring were routinely performed.
Bilateral arterial catheters were placed to monitor systemic
and cerebral perfusion pressure during cardiopulmonary
bypass (CPB). The aortic arch was approached through a
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cannulations were routinely used to establish CPB. The
nondissecting ascending aorta with no atherosclerotic le-
sions was used for CPB.
RAxA cannulation was primarily added for antegrade
cerebral perfusion in patients with aortic dissection or se-
vere atherosclerosis in the ascending aorta or aortic arch.
The RAxA was exposed through a 5- to 7-cm skin incision
at the right axilla, and a 12F to 14F straight cannula was
inserted into the RAxA.5,6 Left atrial venting was initiated
through the right upper pulmonary vein. The three cere-
bral branches of the brachiocephalic artery (BCA), left
common carotid artery (LCCA), and left subclavian artery
were exposed and encircled.
After systemic cooling to 25C (bladder temperature)
for circulatory arrest, cardiac arrest was achieved by ante-
grade and selective deliveries of cardioplegic solution into
both coronary oriﬁces, and SACP was established at the
rate of 500 mL/min for the BCA and 200 mL/min for
LCCA and left subclavian artery using two different roller
pumps separating from the systemic circulation by inserting
14F to 18F balloon catheters into the three cerebral
branches. When cannulation of the RAxA was used, the
BCA was clamped for cerebral perfusion. AxA perfusion
was adjusted to maintain perfusion pressure between 40
and 60 mm Hg. To prevent postoperative cerebral edema,
mannitol was administrated during SACP.
The distal aortic arch was completely separated off at
the borderline between the lesion and normal aorta, and
a stepwise technique was generally used for distal anasto-
mosis in 147 patients (57%). Moreover, direct distal anasto-
mosis with a four-branched prosthetic graft was performed if
at all possible. Femoral artery perfusion was used to ﬂush out
debris after open distal anastomosis. After antegrade perfu-
sion through the branch of the graft was restarted, three
cerebral vessels and the proximal aorta were reconstructed.
Statistical analysis. Continuous data are presented as
mean 6 standard deviation and were analyzed using two-
tailed t-tests or compared with a Mann-Whitney U test
for independent data, as appropriate. Categoric variables
are given as a count and percentage of patients and were
compared using c2 or the Fisher exact test. Survival rates
were estimated using Kaplan-Meier analysis, and survival
curves were compared using the log-rank test. Risk factors
for death were assessed with a multivariable Cox propor-
tional hazards model. A P value of <.05 was statistically
considered signiﬁcant. All data were analyzed using JMP
9.0 software (SAS Institute Inc, Cary, NC).
In addition, we performed adjustment for signiﬁcant
differences in the baseline characteristics of patients with
propensity score-matching using a 1:1 nearest neighbor
matching algorithm with a 60.03 caliper and no replace-
ment, yielding 70 propensity score-matched observations.
The propensity score was estimated using a multivariate
logistic regression model with the variable of use of AxA
cannulation given by other studies, and the 19 baseline
characteristics entered as covariates.9 The model ﬁt and
predictive power was measured with the C statistic(0.80). We compared standardized differences for all cova-
riates between before and after matching to assess prematch
imbalance and postmatch balance. We also performed
paired comparisons of intraoperative and postoperative
data by using conditional logistic regression analysis for cat-
egorical variables and paired t-test for continuous variables.
RESULTS
Patient demographics. In unmatched comparison, a
signiﬁcantly younger mean age (68.5 6 12.2 vs 74.8 6
8.0 years; P < .001) and higher New York Heart Associa-
tion (NYHA) class (1.2 6 1.2 vs 0.9 6 1.0; P ¼ .023) was
found in patients with RAxA cannulation. A greater per-
centage of patients with atherosclerotic disease of the aortic
arch (39% [56 of 142] vs 20% [24 of 118]; P ¼ .001),
emergency operation (48% [68 of 142] vs 17% [20 of
118]; P < .001), and aortic dissection (54% [76 of 142]
vs 20% [24 of 118]; P < .001) were observed in the group
with RAxA cannulation. Preoperative patient characteristics
in the 70 propensity score-matched pairs did not differ
signiﬁcantly, and the preoperative bias was proved to be
well adjusted (Table I).
Intraoperative parameter. Although signiﬁcantly
longer operative and cardiac arrest times in patients with
RAxA cannulation were found in unmatched pairs, there
were no signiﬁcant differences in the matched comparison.
However, lower body circulatory arrest time was signiﬁ-
cantly longer in patients without RAxA cannulation
(58 6 18 minutes vs 69 6 20 minutes; P ¼ .001). The
greater percentage of patients with ascending aorta cannu-
lation was found in patients without RAxA cannulation
(20% [14 of 70] vs 79% [55 of 70]; P < .001; Table II).
Postoperative mortality and morbidity. The overall
30-day mortality was 5.0% (13 of 260) and in-hospital
mortality was 6.5% (17 of 260). Postoperative new stroke
(including transient neurologic disorder) was observed in
17 patients (6.5%). There were no signiﬁcant differences
between matched pairs in 30-day (2.9% [2 of 70] vs 5.7%
[4 of 70]; P ¼ .415) and in-hospital death (5.7% [4 of 70]
vs 5.7% [4 of 70]; P ¼ 1.000). Although the difference in
the occurrence of postoperative stroke between patients
with and without RAxA perfusion was not signiﬁcant (8.6%
[6 of 70] vs 8.6% [6 of 70]; P ¼ 1.000), the new occur-
rence rate of postoperative paraparesis, deﬁned as a partial
and transient paralysis affecting the lower limbs, was lower in
patientswithRAxAperfusion (0% [0of 70] vs 4.3% [3of 70];
P ¼ .067). In addition, postoperative renal function (esti-
mated creatinine clearance) was signiﬁcantly lower in pa-
tients with RAxA cannulation (42.6 6 23.0 mL/min vs
52.06 26.9 mL/min; P ¼ .023; Table III).
Midterm outcome and risk of death. The mean
follow-up period was 1057 6 686 days (range, 1-2716
days; median, 1008 days). The 5-year survival was 90.6%
overall and 89.6% for patients with RAxA perfusion. There
was no signiﬁcant difference in survival between patients
with and without RAxA perfusion in both unmatched and
matched pairs by Kaplan-Meier analysis (Fig 1). Univariate
analysis revealed age, atherosclerotic disease of the
Table II. Unmatched and matched comparison of operative data
Variablesa
Unmatched pair Matched pair
AxAþ (n ¼ 142) AxA (n ¼ 118) P AxAþ (n ¼ 70) AxA (n ¼ 70) P
Operative time, minutes 464 6 114 423 6 98 .002 446 6 106 441 6 107 .748
CPB time, minutes 238 6 62 225 6 57 .092 224 6 53 234 6 68 .293
Cardiac arrest time, minutes 148 6 38 137 6 34 .020 136 6 30 139 6 38 .682
Cerebral perfusion time, minutes 135 6 31 133 6 30 .649 132 6 30 134 6 30 .573
Lower body circulatory arrest time, minutes 62 6 19 65 6 20 .215 58 6 18 69 6 20 .001
Minimum body temperature, C 24.0 6 1.8 24.1 6 2.0 .562 23.9 6 1.8 23.9 6 2.2 .867
Ascending aorta cannulation 17 (12) 95 (81) <.001 14 (20) 55 (79) <.001
Stepwise distal anastomosis 89 (63) 58 (49) .033 43 (61) 38 (54) .423
Concomitant cardiac surgery 49 (35) 42 (36) .896 28 (40) 26 (37) .739
AxA, Axillary artery; CPB, cardiopulmonary bypass.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
Table I. Unmatched and matched comparison of preoperative characteristics
Variablesa
Unmatched pair Matched pair
AxAþ (n ¼ 142) AxA (n ¼ 118) P AxAþ (n ¼ 70) AxA (n ¼ 70) P
Age, years 68.5 6 12.2 74.8 6 8.0 <.001 73.1 6 8.4 73.1 6 9.4 .976
Female sex 41 (29) 38 (32) .590 23 (33) 21 (30) .724
Body surface area, m2 1.66 6 0.21 1.62 6 0.19 .166 1.62 6 0.19 1.63 6 0.20 .824
Hypertension 116 (82) 98 (83) .871 53 (76) 54 (77) .827
Hyperlipidemia 35 (25) 32 (27) .671 19 (27) 18 (26) .848
Diabetes mellitus 12 (8) 12 (10) .671 7 (10) 9 (13) .617
COPD 7 (5) 8 (7) .598 3 (4) 4 (6) .707
PVD 19 (13) 13 (11) .705 12 (17) 7 (10) .193
Carotid artery stenosis 10 (7) 6 (5) .609 6 (9) 3 (4) .315
Hemodialysis 3 (2) 5 (4) .474 1 (1) 2 (3) .573
Estimated CrCl, mL/min 70.2 6 46.6 61.8 6 28.9 .092 54.3 6 25.4 62.1 6 29.8 .091
Atrial ﬁbrillation 15 (11) 12 (10) 1.000 8 (11) 8 (11) 1.000
Atherosclerotic disease of aortic arch 56 (39) 24 (20) .001 20 (29) 22 (31) .670
Preoperative TND 11 (8) 5 (4) .304 3 (4) 4 (6) .707
Emergency 68 (48) 20 (17) <.001 16 (23) 14 (20) .638
Aortic dissection 76 (54) 24 (20) <.001 19 (27) 19 (27) 1.000
Ruptured aorta 10 (7) 12 (10) .381 6 (9) 6 (9) 1.000
LVEF, % 64.4 6 9.7 65.5 6 9.8 .378 65.2 6 9.1 64.9 6 11.3 .893
NYHA class 1.2 6 1.2 0.9 6 1.0 .023 1.0 6 1.0 1.1 6 1.1 .620
AxA, Axillary artery; CrCl, creatinine clearance; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; NYHA, New York
Heart Association; PVD, peripheral vascular disease; TND, transient neurologic dysfunction.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
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tive transient neurologic dysfunction, operative CPB, car-
diac arrest, cerebral perfusion time, and stepwise distal
anastomosis as covariates (P < .1). By multivariate Cox
proportional-hazards regression, independent predictors
of midterm death were atherosclerotic disease of the
ascending aorta and aortic arch (hazard ratio, 3.3; 95%
conﬁdence interval, 1.3-8.4; P ¼ .012) and a ruptured
aorta (hazard ratio, 4.0; 95% conﬁdence interval, 1.3-11.6;
P ¼ .019; Fig 2; Table IV).
Subanalysis of RAxA perfusion for patients with
aortic dissection and atherosclerotic disease in the
aorta. Aortic dissection was observed in 100 patients,
and in-hospital death occurred in 6.0% (6 of 100) and
postoperative stroke in 7.0% (7 of 100). RAxA perfusion
was used in 76 patients (76%). In-hospital mortality and
stroke occurrence was 6.6% (5 of 76) and 6.6% (5 of76), and there were no signiﬁcant differences between
those with (P ¼ .547) and without (P ¼ .173) RAxA
perfusion. By log-rank test, RAxA perfusion had no
relevance to the midterm mortality in patients with
aortic dissection (Fig 3, A). Atherosclerotic disease in
the ascending aorta and arch was observed in 80
patients, and in-hospital mortality and occurrence of
postoperative stroke was 13.8% (11 of 80) and 11.3%
(9 of 80), respectively. Additionally, in the 80 patients,
RAxA perfusion was used in 56 patients (70%). The
in-hospital mortality rate was 14.3% (8 of 56), and
stroke occurred in 10.7% (6 of 56), and there were no
signiﬁcant differences in the percentage between with
and without RAxA perfusion (both P ¼ 1.000). The log-
rank test showed RAxA perfusion did not inﬂuence
midterm mortality in patients with atherosclerotic dis-
ease in the aorta (Fig 3, B).
Fig 1. Kaplan-Meier survival on the basis of right axillary artery (RAxA) perfusion. A, Unmatched comparison
between patients with and without RAxA perfusion. B, Matched comparison between patients with and without
RAxA perfusion.
Table III. Matched comparison of postoperative data
Variablea All (N ¼ 260)
Matched pair
PAxAþ (n ¼ 70) AxA (n ¼ 70)
30-day death 13 (5.0) 2 (2.9) 4 (5.7) .415
Hospital death 17 (6.5) 4 (5.7) 4 (5.7) 1.000
Stroke 17 (6.5) 6 (8.6) 6 (8.6) 1.000
Paraparesis 7 (2.7) 0 (0) 3 (4.3) .067
Reexploration for bleeding 5 (1.9) 2 (2.9) 0 (0) .153
Reintubation 14 (5.4) 3 (4.3) 4 (5.7) .658
Initial ventilation time, hours 36.8 6 79.5 40.7 6 93.4 26.1 6 43.6 .305
Mediastinitis 2 (0.8) 0 (0) 0 (0) .
ICU stay, days 5.5 6 8.7 6.2 6 9.7 4.4 6 5.3 .182
Hospital stay, days 28.4 6 20.3 31.1 6 16.6 27.4 6 17.7 .200
AxA, Axillary artery; ICU, intensive care unit.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
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nulation. In the present study, there were 29 patients
(20%) with RAxA perfusion through a side graft and 113
(80%) with direct RAxA cannulation. Operative time
(487 6 90 minutes vs 458 6 119 minutes; P ¼ .045)
and initial ventilation time (78 6 174 hours vs 35 6
49 hours; P ¼ .026) were signiﬁcantly longer in patients
with RAxA perfusion through the graft. However, there
were no signiﬁcant differences in the percentage of hospital
death and stroke (Table V). The 5-year survival rate was
89.4% in patients with RAxA perfusion by graft and 89.7%
in patients with direct RAxA cannulation. However, there
were ﬁve conversions to single femoral artery cannulation
in patients with direct RAxA cannulation, and the causes of
conversion included three injured RAxA, one dissected
RAxA due to guidewire manipulation, and one high pres-
sure of RAxA perfusion.
DISCUSSION
The AxA is usually free of atherosclerosis and can safely
be cannulated directly or with a graft in case severeatherosclerotic change or dissection is found in the
ascending aorta or arch. RAxA perfusion can avoid aortic
manipulation and retrograde ﬂow of femoral artery cannu-
lation.10 As a result, RAxA cannulation is proved to be a
useful option for prevention of cerebral embolism during
CPB,11 and thus RAxA perfusion has been used for various
cardiac and aortic surgeries.12,13 Several groups have reported
better outcomes of RAxA perfusion in aortic dissection
repair14-16 and proximal aortic operation compared with
only femoral artery perfusion.17 In addition, the effect of
RAxA perfusion in aortic arch repair has been reported.5-7
However, there are various preoperative selection biases and
differences in technique (directly or with a graft), and evalu-
ating the real beneﬁt of RAxA perfusion is difﬁcult.8 We
adjusted the selection bias by using a propensity score, and
evaluated the efﬁcacy of RAxA perfusion. To the best of our
knowledge, the present study is the ﬁrst report on a matched
comparison of outcomes between patients with and without
RAxA perfusion in total aortic arch repair with SACP.
In the present study, RAxA perfusion was speciﬁcally
used for patients with atherosclerosis or dissection in the
Table IV. Univariate and multivariate analysis for predictors of midterm mortality
Variables
Univariate analysis Multivariate analysis
HR (95% CI) P Adjusted HR (95% CI) P
RAxA perfusion, þ 1.5 (0.66-3.87) .321
Age, per year 1.0 (1.00-1.09) .081
Atherosclerotic disease of ascending aorta and aortic arch, þ 3.7 (1.6-9.0) .003 3.3 (1.3-8.4) .012
Ruptured aorta, þ 5.7 (2.2-13.6) .001 4.0 (1.3-11.6) .019
Preoperative TND, þ 5.8 (1.9-14.7) .004
Operative time, per minute 1.00 (1.00-1.01) .040
CPB time, per minute 1.01 (1.00-1.01) .012
Cardiac arrest time, per minute 1.02 (1.00-1.03) .007
Cerebral perfusion time, per minute 1.01 (1.00-1.01) .052
Stepwise distal anastomosis, þ 2.7 (1.1-8.1) .037
CI, Conﬁdence interval; HR, hazard ratio; RAxA, right axillary artery; TND, transient neurologic dysfunction.
Fig 2. Kaplan-Meier survival on the basis of preoperative risk factors. A, Comparison between patients with and
without atherosclerotic (Athero) disease of the ascending aorta and aortic arch. B, Comparison between patients with
and without a ruptured aorta.
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class. Younger age, emergency operation, and high NYHA
class were thought to be associated with aortic dissection.
Although there were no signiﬁcant preoperative differences
in the propensity score-matched comparison, lower body
circulatory arrest time was signiﬁcantly shorter in patients
with RAxA perfusion. Balloon insertion into the BCA for
SACP was not required and may be the primary reason for
the reduction of circulatory arrest time. A greater percentage
of ascending aorta cannulation was due to lesions in the
ascending aorta in patients with RAxA perfusion.
The occurrence rate of paraparesis was signiﬁcantly
lower in patients with RAxA perfusion; however, there
were no signiﬁcant differences in mortality and occurrence
of stroke between patients with and without RAxA cannu-
lation. We cannot demonstrate signiﬁcant efﬁcacy of RAxA
cannulation for the prevention of postoperative stroke and
hospital death in patients with dissection and atheroscle-
rosis in the ascending aorta, but the results conversely
showed that equivalent excellent outcomes were obtained
in patients with aortic dissection and shaggy aorta by using
RAxA perfusion.A BCA clamp was required to establish SACP, and
direct clamp and guidewire manipulation for direct arterial
cannulation can be primary causes of embolism in patients
with atherosclerosis of the aortic arch. Atherosclerosis of
the ascending and arch and ruptured aorta were detected
as signiﬁcant risk factors of death in this study, and crucial
effects of an atherothrombotic aorta on short-term and
long-term outcomes have been reported in total aortic
arch repair.18 The unexpected rapid ﬂow jet of RAxA
perfusion was thought to be a risk for embolism of the
LCCA in patients with atherosclerosis in the aorta.19
Considering these factors, a more modiﬁed technique of
RAxA perfusion will be required for completely eradicating
thromboembolism in patients with an atherothrombotic
aorta.
On one hand, AxA perfusion through a side graft did
not require guidewire manipulation, and signiﬁcantly
lower cannulation-related morbidity rate and stroke
occurrence were reported in patients with use of a side
graft compared with direct cannulation.20,21 On the other
hand, pitfalls and complications associated with RAxA
cannulation have been reported, including new dissection,
Table V. Comparison of operative and postoperative
data between AxA perfusion with a graft and direct
cannulation
Variablea
Graft
(n ¼ 29)
Direct
(n ¼ 113) P
Operative time, minutes 487 6 90 458 6 119 .045
CPB time, minutes 234 6 46 229 6 65 .940
Cardiac arrest time, minutes 139 6 31 150 6 40 .231
Cerebral perfusion
time, minutes
139 6 27 134 6 33 .508
Lower body circulatory
arrest time, minutes
64 6 20 61 6 19 .118
30-day death 2 (6.9) 6 (5.3) .666
Hospital death 3 (10.3) 9 (8.0) .710
Stroke 4 (13.8) 6 (5.3) .121
Paraparesis 0 (0) 2 (1.8) 1.000
Reexploration for bleeding 2 (6.9) 2 (1.8) .185
Reintubation 2 (6.9) 7 (6.2) 1.000
Initial ventilation time,
hours
78 6 174 35 6 49 .026
Mediastinitis 0 (0) 1 (0.9) 1.000
ICU stay, days 6.8 6 2.0 6.4 6 10.9 .967
Hospital stay, days 28.8 6 16.1 30.4 6 25.2 .595
CPB, Cardiopulmonary bypass; ICU, intensive care unit.
aContinuous data are shown as mean 6 standard deviation and categoric
data as number (%).
Fig 3. Kaplan-Meier survival on the basis of right axillary artery (RAxA) perfusion. A, Comparison between patients
with and without RAxA perfusion in patients with atherosclerotic disease of ascending aorta and aortic arch. B,
Comparison between patients with and without RAxA perfusion in patients with aortic dissection.
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arterial injury.22-24 In this study, the differences in early
and midterm postoperative courses between direct can-
nulation and perfusion via graft were not signiﬁcant.
However, cannulation-related trouble occurred in 4.2%
of patients with direct RAxA cannulation. These ﬁndings
indicated that the priority of the RAxA cannulation tech-
nique (direct cannulation or perfusion via graft) remains
still controversial.
RAxA perfusion is one of the most useful options for
open aortic arch repair with SACP, and midterm survival
of patients with RAxA perfusion was satisfactory in ourstudy. However, RAxA perfusion did not prevent stroke
in patients with atherosclerotic lesions of the aortic arch,
and deciding the optimal cannulation site in these patients
was still difﬁcult. Careful selection of the cannulation site
according to the patient’s pathology and modiﬁed ap-
proaches for the prevention of embolism, such as gentle
and cautious guidewire manipulation or ﬂushing out the
debris before BCA clamp, are required to improve the efﬁ-
cacy of RAxA perfusion.
Our study has several limitations. First, this was a non-
randomized retrospective observational study. Second,
propensity score was used to reduce selection bias, but
the matching is limited, and arbitrariness was not fully de-
nied. Finally, the RAxA was used as one of the cannulation
sites to establish SACP in all cases, and efﬁcacy of single use
of RAxA perfusion was not evaluated; therefore, ascending
aorta and femoral artery cannulation may inﬂuence the
results.
CONCLUSIONS
RAxA perfusion can be a useful option for total aortic
arch repair with SACP, and excellent midterm outcomes
were obtained. However, an atherothrombotic aorta was
detected as a risk factor of midterm death, and RAxA
perfusion was not found to completely prevent stroke in
patients with atherothrombotic aorta.
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